Given that predicting the prognosis of CRC patients using a single biomarker or clinical characteristic is often difficult, we developed a comprehensive prognostic nomogram model that integrates CLDN18 and FTCD with clinical factors like age and gender. The gene discussed is FTCD; the disease is colorectal carcinoma.